Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

MiMedx Group Inc (MDXG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow MiMedx's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6.16 -0.10    -1.60%
21:00:01 - Closed. Currency in USD ( Disclaimer )
After Hours
6.20
+0.04
+0.65%
22:15:24 - Real-time Data
  • Volume: 879,808
  • Bid/Ask: 6.35 / 7.97
  • Day's Range: 6.12 - 6.28
Type:  Equity
Market:  United States
MiMedx 6.16 -0.10 -1.60%

MiMedx Company Profile

 
Read the MiMedx company profile to learn more about the business and the management team. View MiMedx Group Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

867

Equity Type

ORD

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins. The company’s patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company’s products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was incorporated in 2011 and is headquartered in Marietta, Georgia.

Contact Information

Address 1775 West Oak Commons Court, NE
Marietta, 30062
United States
Phone 770 651 9100
Fax -

Top Executives

Name Age Since Title
M. Kathleen Behrens Wilsey 68 2019 Independent Chairman of the Board
Robert Guldberg - - Member of Regenerative Medicine Scientific Advisory Board
Anthony Atala 65 2022 Member of Regenerative Medicine Scientific Advisory Board
Philip G. Conaghan - 2022 Member of Regenerative Medicine Scientific Advisory Board
Vibeke S. Strand - 2022 Member of Regenerative Medicine Scientific Advisory Board
Regis J. O’Keefe - 2022 Member of Regenerative Medicine Scientific Advisory Board
Asger Bihlet - 2022 Member of Regenerative Medicine Scientific Advisory Board
Michael J. Giuliani 69 2020 Independent Director
Eric W. Carson - 2022 Member of Regenerative Medicine Scientific Advisory Board
Kris John Alden - 2022 Member of Regenerative Medicine Scientific Advisory Board
Cato T. Laurencin 64 2020 Independent Director
Phyllis Irene Gardner 72 2021 Independent Director
Olga Kubassova - 2022 Member of Regenerative Medicine Scientific Advisory Board
Scott Rodeo - 2022 Member of Regenerative Medicine Scientific Advisory Board
Constance Chu - 2022 Member of Regenerative Medicine Scientific Advisory Board
James R. Andrews 80 - Member of Medical Advisory Board
Glenn Gaston - - Member of Medical Advisory Board
Thomas Zdeblick - - Member of Medical Advisory Board
K. Todd Newton 60 2019 Independent Director
William A. Hawkins 69 2020 Independent Preferred Director
Martin Paul Sutter 68 2020 Independent Preferred Director
James L. Bierman 70 2019 Independent Director
Dorothy E. Puhy 72 2024 Independent Director
Tiffany P. Olson 65 2024 Independent Director
Joseph H. Capper 60 2023 CEO & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MDXG Price Commentary

Write your thoughts about MiMedx Group Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email